3.3. Biology—Opioid Binding Assay

SP Sandra Piras
GM Gabriele Murineddu
GL Giovanni Loriga
AC Antonio Carta
EB Enrica Battistello
SM Stefania Merighi
SG Stefania Gessi
PC Paola Corona
BA Battistina Asproni
RI Roberta Ibba
VT Veronika Temml
DS Daniela Schuster
GP Gérard Aimè Pinna
request Request a Protocol
ask Ask a question
Favorite

Ligand binding assays were determined for compounds under study, at μ-, δ-, and κ-opioid receptors, as described in detail elsewhere [30,31]. Binding affinities for μ-, δ-, and κ-opioid receptors were determined by displacing, respectively, [3H]DAMGO (1 nM), [3H]DADLE (1 nM) and [3H]U69593 (1 nM) from mouse brain membrane binding sites. Brain membranes were incubated with the appropriate [3H]-ligand in 50 mM Tris–HCl buffer, pH 7.4, at 25 °C for 60 min in the absence or presence of 10 μM naloxone. IC50 values were determined from log dose displacement curves, and Ki values were calculated from the obtained IC50 values by means of the equation of Cheng and Prusoff [32].

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A